Mario Ermani
Impact in
- Genetics top 0.2%
- Glioma Diagnosis and Treatment
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 40
- Glioma Diagnosis and Treatment 38
-
- Brain Metastases and Treatment 21
- Co-authors
- Alba A. Brandes (39 shared papers)Enrico Franceschi (23 shared papers)Alicia Tosoni (14 shared papers)V. Blatt (9 shared papers)Roberta Bertorelle (4 shared papers)G. Frezza (2 shared papers)F. Spagnolli (2 shared papers)Pietro Amistà (10 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer (6 papers)Neurology (5 papers)Journal of Neuro-Oncology (3 papers)Annals of Oncology (2 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Mario Ermani
57 papers receiving 3.5k citations
Mario Ermani's Hit Papers
Peers
Comparison fields: 5 of 107
- Genetics 2.6k
- Cancer Research 688
- Pulmonary and Respiratory Medicine 1.3k
- Internal Medicine 118
- Neurology 403
Countries citing papers authored by Mario Ermani
This map shows the geographic impact of Mario Ermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Ermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Ermani more than expected).
Fields of papers citing papers by Mario Ermani
This network shows the impact of papers produced by Mario Ermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Ermani. The network helps show where Mario Ermani may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Ermani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients Hit paper breakdown → | 2008 | 634 |
| 2 | 2009 | 289 | |
| 3 | 2006 | 185 | |
| 4 | 2009 | 181 | |
| 5 | 1997 | 164 | |
| 6 | 2010 | 149 | |
| 7 | 2006 | 142 | |
| 8 | 2003 | 132 | |
| 9 | 2000 | 106 | |
| 10 | 2004 | 105 | |
| 11 | 2007 | 100 | |
| 12 | 2010 | 99 | |
| 13 | 2004 | 99 | |
| 14 | 2004 | 93 | |
| 15 | 2001 | 83 | |
| 16 | 2009 | 73 | |
| 17 | 1999 | 70 | |
| 18 | 2008 | 62 | |
| 19 | 2017 | 60 | |
| 20 | 2003 | 57 |
About Mario Ermani
Mario Ermani is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Epidemiology, having authored 58 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (38 papers), Brain Metastases and Treatment (21 papers), Cancer Treatment and Pharmacology (8 papers), Meningioma and schwannoma management (8 papers), Histone Deacetylase Inhibitors Research (7 papers), Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Genetics (2.6k citations), Cancer Research (688 citations), Pulmonary and Respiratory Medicine (1.3k citations), Internal Medicine (118 citations) and Neurology (403 citations). Mario Ermani has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Alba A. Brandes, Enrico Franceschi, Alicia Tosoni, V. Blatt, Roberta Bertorelle, G. Frezza, F. Spagnolli, Pietro Amistà, Fabio Calbucci and Annalisa Pession. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Neurology, Journal of Neuro-Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.